electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Companyâs portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
äŒæ¥ã³ãŒãECOR
äŒç€ŸåelectroCore, Inc.
äžå Žæ¥Jun 22, 2018
æé«çµå¶è²¬ä»»è
ãCEOãGoldberger (Daniel S)
åŸæ¥å¡æ°73
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 22
æ¬ç€Ÿæåšå°200 Forge Way
éœåžROCKAWAY
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·07866
é»è©±çªå·19732900097
ãŠã§ããµã€ãhttps://www.electrocore.com/
äŒæ¥ã³ãŒãECOR
äžå Žæ¥Jun 22, 2018
æé«çµå¶è²¬ä»»è
ãCEOãGoldberger (Daniel S)